Science Explorer Back to mapMap
Discussion
Researcher · Rega Institute for Medical Research · Belgium

Erik De Clercq

Erik De Clercq publishes mostly in Organic Chemistry, Infectious Diseases and Epidemiology, on topics such as HIV/AIDS drug development and treatment, HIV Research and Treatment and Cytomegalovirus and herpesvirus research.

ORCID 0000-0002-2985-8890 OpenAlex
World rank
#648,856
of 7,710,434 ranked researchers
Rank in Belgium
#5,809
of 67,186
Works
3,864
Citations
141k
Citations per work
36.5
h-index
161
i10-index 2,083Top 0.1% in Organic Chemistry
Erik De Clercq

What does Erik De Clercq research?

Erik De Clercq's work is mostly in Medicine (31%), Chemistry (20%), Immunology and Microbiology (14%).

Health Sciences: 1,206 works · 31.2% of their workMedicine: 1,206 works · 31.2% of their workInfectious Diseases: 668 works · 17.3% of their workEpidemiology: 537 works · 13.9% of their workLife Sciences: 1,005 works · 26.0% of their workImmunology and Microbiology: 526 works · 13.6% of their workVirology: 371 works · 9.6% of their workImmunology: 155 works · 4.0% of their workBiochemistry, Genetics and Molecular Biology: 479 works · 12.4% of their workMolecular Biology: 479 works · 12.4% of their workEverything else: 900 works · 23.3% of their workPhysical Sciences: 753 works · 19.5% of their workChemistry: 753 works · 19.5% of their workOrganic Chemistry: 753 works · 19.5% of their workTHEIR WORKErik De Clercq3,864works
Life Sciences26%Physical Sciences20%Health Sciences31%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Health Sciences1,20631.2%
    1. Medicine1,20631.2%
  2. Life Sciences1,00526.0%
    1. Immunology and Microbiology52613.6%
    2. Biochemistry, Genetics and Molecular Biology47912.4%
  3. Everything else90023.3%
    1. Chemistry75319.5%
  1. 1Organic Chemistry20% of their works
  2. 2Infectious Diseases17% of their works
  3. 3Epidemiology14% of their works
  4. 4Molecular Biology12% of their works
  5. 5Virology10% of their works
  6. 6Immunology4% of their works

Research topics

Which keywords describe Erik De Clercq's research?

The keywords of their largest research topics: Antiretroviral Therapy, Drug Resistance, HIV Infection, Immune Response, Vaccine, AIDS, HIV and Drug Discovery.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Antiretroviral Therapy2,5042 topics
  2. Drug Resistance1,5331 topic
  3. HIV Infection1,5331 topic
  4. Immune Response1,4092 topics
  5. Vaccine1,4092 topics
  6. AIDS9711 topic
  7. HIV9711 topic
  8. Drug Discovery7802 topics
  9. Cytomegalovirus5201 topic
  10. Infection5201 topic
  11. Enzyme Regulation5071 topic
  12. Nucleotide Metabolism5071 topic
  13. Synthesis4691 topic
  14. Triazines4691 topic
  15. Herpes Zoster4381 topic
  16. Herpesviruses4381 topic
  17. Click Chemistry3111 topic
  18. Copper-Catalyzed Cycloaddition3111 topic
  19. Heterocyclic Compounds2781 topic
  20. Medicinal Chemistry2781 topic

Where does Erik De Clercq work?

Erik De Clercq's main affiliation in the publication record is Rega Institute for Medical Research, Belgium.

How many publications and citations does Erik De Clercq have?

OpenAlex counts 3,864 works and 140,896 citations for Erik De Clercq, an h-index of 161, ranking #648,856 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Erik De Clercq. Posts are plain text and can be reported.